David Davidson, Chief Medical Officer at bluebird bio, Inc. (BLUE), sold 8,620 shares at $121.68 ($1.1M) on 2019-06-06, disclosed to the SEC on 2019-06-10.
Seasonal sale ($1.1M) by Chief Medical Officer — this insider has traded BLUE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.68 | 2,216 | $270K | 25.6% |
| 2 | $121.68 | 2,216 | $270K | 25.6% |
| 3 | $122.43 | 1,344 | $165K | 15.6% |
| 4 | $122.43 | 1,344 | $165K | 15.6% |
| 5 | $124.23 | 1,500 | $186K | 17.7% |
| Total | $122.36 avg | 8,620 |
| $1.1M |
| 100% |
| Filing → |
| BLUE | SELL | 2021-02-18 | $20K | — | Filing → |
| BLUE | SELL | 2021-02-04 | $3K | — | Filing → |
| BLUE | SELL | 2021-01-08 | $288K | — | Filing → |